Univasc
Active Ingredient(s): MoexiprilFDA Approved: * April 19, 1995
Pharm Company: * SCHWARZ PHARMA
Category: Blood Pressure
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Univasc Overview
Moexipril hydrochloride is a potent orally active nonsulfhydryl angiotensin converting enzyme inhibitor (ACE inhibitor)[1] which is used for the treatment of hypertension and congestive heart failure. Moexipril can be administered alone or with other antihypertensives or diuretics.[2] It works by inhibiting the conversion of angiotensin I to angiotensin II.[3] Moexipril is available from Schwarz Pharma under the trade name Univasc.[3&...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Moexipril
Recent Univasc Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Moexipril
- Tablet: 15mg, 7.5mg
NDC Database Records for Univasc: (2 results)
Sorted by National Drug CodeOther drugs which contain Moexipril or a similar ingredient: (3 results)
- MOEXIPRIL 1 discussion
- HYDROCHLOROTHIAZIDE, HCTZ + MOEXIPRIL
- UNIRETIC Hydrochlorothiazide, HCTZ + Moexipril2 discussions